U-Blot® Research Grade LerodalcibepCat. No. WA3064$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade LerodalcibepCat. No. WA3064
U-Blot® Research Grade LerdelimumabCat. No. WA3063
U-Blot® Research Grade Lepunafusp alfaCat. No. WA3062
U-Blot® Research Grade LenzilumabCat. No. WA3061
U-Blot® Research Grade LenvervimabCat. No. WA3060
U-Blot® Research Grade lenipagrusin alfaCat. No. WA3059
U-Blot® Research Grade LenerceptCat. No. WA3058
U-Blot® Research Grade LemzoparlimabCat. No. WA3057
U-Blot® Research Grade LemalesomabCat. No. WA3056
U-Blot® Research Grade ledostomigCat. No. WA3055
U-Blot® Research Grade lecomkafusp alfaCat. No. WA3054
U-Blot® Research Grade lecankitugCat. No. WA3053